-
Posted by
Two Blokes Jun 22 -
Filed in
Stock
-
4 views
Aurora Cannabis recently reported improved Q4-2025 results. ACB's international medical cannabis sales are increasing revenues. The company reported record revenues, but low gross profit and weak 2026 outlook.
